Nvidia Stock Is Back at Its May Record. Its Quarterly Revenue Is 41% Higher.

Nvidia shares returned to a record near $237.87 as fiscal Q2 2027 revenue reached $96.2B, up 106% year over year and 41% above the $68.1B reported in fiscal Q4 when the stock last peaked in May. Data-center revenue rose to $89.0B, exceeding 90% of total sales, while adjusted EPS increased to $2.22 from $1.59 in fiscal Q4; management guided fiscal Q3 revenue to $108B, plus or minus 2%. With trailing adjusted EPS up about 50% to $6.95, the adjusted P/E has declined to roughly 34x from 51x at the prior record, though projected sequential revenue growth of about 12% signals moderation from recent growth rates.

Analysis

The key underwriting change is not the headline multiple but the durability of hyperscaler capex behind it. NVDA now requires a much larger absolute quarterly demand increment to sustain sequential growth, so even modest cloud-provider digestion would create an outsized deceleration narrative and multiple compression. The relevant leading indicators over the next 1-3 months are MSFT, AMZN, GOOGL and META capex commentary, lead times at TSM, and whether networking attach rates hold; these are more informative than NVDA's reported earnings, which remain supply-constrained and backward-looking.

Competitive spillover is asymmetric. AVGO is the principal beneficiary if large customers increasingly internalize inference workloads through custom ASICs, while AMD gains only if customers prioritize a second merchant source rather than vertically integrated alternatives. ANET, VRT, ETN and PWR retain exposure to physical AI build-outs even if accelerator share shifts; however, their risk is that a pause in GPU shipments delays entire site commissioning cycles rather than merely reallocating silicon spend. NVDA's adjusted valuation should also be treated cautiously because the revised non-GAAP presentation still leaves investors anchoring to earnings measures that can obscure the growing economic cost of stock compensation and investment-related GAAP volatility.

Consensus appears too focused on whether the stock is "cheaper" versus its prior peak. A lower trailing multiple is deserved only if elevated gross margins and customer concentration remain stable through the next platform transition; the bear case is not a collapse in AI demand but a normalization from capacity scarcity to competitive procurement. Near term, the setup is constructive into any confirmation that hyperscaler capex budgets are being raised, but at a record valuation the upside likely requires estimate revisions rather than multiple expansion. A guide below the current revenue midpoint, material gross-margin erosion, or a major customer disclosing custom-silicon substitution would falsify the constructive thesis quickly.

Key Decisions for Investors

• Maintain a tactical long NVDA only through the next hyperscaler earnings cycle; add on post-earnings weakness rather than chase new highs. Target 10-15% upside if FY estimates continue to rise, with a 7-8% stop or reduction trigger on guidance that implies sub-10% sequential growth or gross-margin disappointment.
• Express AI infrastructure exposure as long NVDA / short AVGO only if channel checks show merchant GPU demand remains supply-limited and custom-ASIC deployments are slipping. Use a 3-month horizon; close if AVGO reports material incremental AI semiconductor bookings or a major hyperscaler discloses accelerated internal-chip adoption.
• Prefer a diversified second-order basket of VRT, ETN and PWR over additional high-beta semiconductor exposure for 6-18 months. These names monetize power-density and grid constraints that persist across GPU and ASIC architectures, though position sizing should account for their sensitivity to a broad data-center construction pause.
• Buy 3-month NVDA put spreads only as event protection around hyperscaler capex disclosures, not as a standalone bearish position. The missing data is customer-level order concentration and cancellation rights; absent evidence of digestion, an outright short faces continued earnings-revision risk.